Z-100, an immunomodulatory extract of Mycobacterium tuberculosis strain Aoyama B, prevents spontaneous lymphatic metastasis of B16-BL6 melanoma

Biological & Pharmaceutical Bulletin
Takayuki HoriiMineo Takei

Abstract

Lymphatic metastasis is common in advanced-stage carcinoma and is associated with a poor prognosis. However, few effective treatments to inhibit it are available. Z-100 is an immunomodulatory extract of Mycobacterium tuberculosis strain Aoyama B that contains polysaccharides such as arabinomannan and mannan. Here, we investigated the inhibitory effect of Z-100 on spontaneous lymphatic metastasis. C57BL/6N mice injected subcutaneously with B16-BL6 melanoma cells in the right hind footpad were administered Z-100 subcutaneously in the right inguinal region on a daily basis. On day twenty-one after the injection, the right inguinal lymph nodes were excised, and the extent of metastasis, the number of immune cells, and the amount of granzyme B protein in the lymph nodes were examined. We also investigated the combined effect of Z-100 and irradiation in this model. Results showed that Z-100 reduced number of animals with metastasis, with respective metastasis rates of 85.7%, 42.9%, 7.1% and 0.0% in saline, 0.1 mg/kg Z-100, 1 mg/kg Z-100 and 10 mg/kg Z-100 group. Further, mice that had been given Z-100 were found to have more immune cells and granzyme B protein in the lymph nodes than control mice. The combination of low dose Z-100 an...Continue Reading

References

Aug 1, 1981·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·H KobatakeH Kushida
Dec 10, 1999·Proceedings of the National Academy of Sciences of the United States of America·D M UnderhillA Aderem
Nov 8, 2001·Journal of the National Cancer Institute·H E WileyS T Hwang
May 20, 2003·Immunological Reviews·Sarah J LordR Chris Bleackley
Dec 15, 2005·The Journal of Experimental Medicine·Shihao ChenMinoru Fukuda
Nov 4, 2006·The Lancet Oncology·David S P TanStanley B Kaye
Oct 24, 2007·Microvascular Research·Bernadette M M Zwaans, Diane R Bielenberg
Feb 29, 2008·Annual Review of Immunology·Dipanjan Chowdhury, Judy Lieberman
Apr 25, 2008·Blood·Fumiko Marttila-IchiharaSirpa Jalkanen
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John A OlsonUNKNOWN American College of Surgeons Oncology Group Trials Z0010 and Z0011
Jan 24, 2009·Immunobiology·Umut Gazi, Luisa Martinez-Pomares
Jul 1, 2009·Expert Opinion on Drug Delivery·Yumei XieM Laird Forrest
Jan 12, 2010·Oral Oncology·Nádia Lago CostaAline Carvalho Batista
Jul 27, 2010·Trends in Immunology·Shannon BurkeEnnio Carbone
Nov 3, 2010·International Journal of Oncology·Ilona Rousalova, Evzen Krepela
Feb 10, 2011·JAMA : the Journal of the American Medical Association·Armando E GiulianoMonica Morrow
Jun 28, 2011·Advanced Drug Delivery Reviews·Jennifer D McAllaster, Mark S Cohen
Oct 18, 2011·Cell·Scott Valastyan, Robert A Weinberg
Nov 26, 2011·Cancer Immunology, Immunotherapy : CII·Ursula J E SeidelThorbald van Hall
Dec 22, 2011·Cancer Immunology, Immunotherapy : CII·Christina S Mullins, Michael Linnebacher
Oct 6, 2012·Critical Reviews in Oncology/hematology·Antonin LevyEric Deutsch
Mar 16, 2013·The Lancet Oncology·Viviana GalimbertiUNKNOWN International Breast Cancer Study Group Trial 23-01 investigators

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.